16.5.2024
15.5.2024
18
May
2024
22
24
Find more news and events
Suomeksi
In English
A new study from the University of Eastern Finland and the University of Tübingen helps to explain what defines how long a drug molecule stays bound to its target.
One of the most comprehensive ocular pharmacokinetic studies including metabolism so far provides valuable information for ocular drug development.
Most of the disease-modifying antirheumatic drugs were not associated with the risk of Parkinson's disease, a new register-based study shows. An exception was the use of chloroquine or hydroxychloroquine which associated with a lower risk.